Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01307852 · ClinicalTrials.gov registry record · Phase 1
In Vivo Dosimetry During Prostate Cancer Radiotherapy
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT01307852: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT01307852 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01307852, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if a rectal balloon with attached radiation detectors can be used to help researchers monitor the dose of external beam radiation that is delivered to the prostate during treatment. This may help researchers better understand the side effects of radiation therapy, such as rectal bleeding, and may lead to changes in treatment planning or treatment delivery.
Interventions
- DEVICE Plastic Scintillation Detectors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01307852
The ClinicalTrials.gov registry entry for NCT01307852 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plastic Scintillation Detectors is the first listed.
NCT01307852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01307852 about?
NCT01307852 is a clinical study titled "In Vivo Dosimetry During Prostate Cancer Radiotherapy". The goal of this clinical research study is to learn if a rectal balloon with attached radiation detectors can be used to help researchers monitor the dose of external beam radiation that is delivered to the prostate during treatment. This may help researchers better understand the side effects of r...
What is the current status of trial NCT01307852?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2011-11. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01307852?
The interventions under investigation include: Plastic Scintillation Detectors (DEVICE).
Who is sponsoring clinical trial NCT01307852?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.